TRAM Snapshot of App at Pub for Oppostn

BICKAN

OSE Immunotherapeutics

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88103678 FILING DATE 09/04/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY KELLY, JOHN M
L.O. ASSIGNED 119

PUB INFORMATION

RUN DATE 12/29/2018
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 12/28/2018
LITERAL MARK ELEMENT BICKAN

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT BICKAN
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME OSE Immunotherapeutics
ADDRESS 22 Boulevard Benoni Goullin
Nantes, 44200
ENTITY 99-société anonyme (sa)
CITIZENSHIP France

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT (Based on 44(e)) (Based on Intent to Use) Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT (Based on 44(e)) (Based on Intent to Use) Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT (Based on 44(e)) (Based on Intent to Use) Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

FOREIGN INFORMATION

PRIORITY CLAIMED SEC. 44(D) ON France
APPLICATION NO. 184456661
APPLICATION FILING DATE 05/29/2018
FOREIGN REG NO. 184456661
FOREIGN REG DATE 10/26/2018
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 05/29/2028
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
12/28/2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 011
12/28/2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
12/28/2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
12/27/2018 ALIE A ASSIGNED TO LIE 008
12/20/2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
12/15/2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
12/15/2018 GNRT F NON-FINAL ACTION E-MAILED 005
12/15/2018 CNRT R NON-FINAL ACTION WRITTEN 004
12/14/2018 DOCK D ASSIGNED TO EXAMINER 003
09/11/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
09/07/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Patrick J. Jennings
CORRESPONDENCE ADDRESS PATRICK J. JENNINGS
PILLSBURY WINTHROP SHAW PITTMAN, LLP
1200 SEVENTEENTH STREET, NW
WASHINGTON, DC 20036
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed